Riskpilot← Back to searchSign inGet full accessKALBAKKENKLINIKKEN AS
ASActiveOrg 915378404Trondheimsveien 391, 0953 OsloMedical specialists activities · NACE 8622Est. 20156 employeeswww.sykehusetosloost.no
Revenue 2024
NOK 16,2M
+19% vs 2023
EBITDA margin
3.0%
+168% vs 2023
Equity ratio
18.7%
Financial strength
Net profit 2024
NOK -2,5M
+23% vs 2023
| Revenue | NOK 16,2M | +19% |
| EBITDA | NOK 481K | +168% |
| Net profit | NOK -2,5M | +23% |
| Total assets | NOK 16,5M | -2% |
| Equity | NOK 3,1M | -45% |
| Employees | 6 | — |
Legal name
KALBAKKENKLINIKKEN AS
Org number
915378404
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
13. mai 2015
Share capital
NOK 990 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Eie og drive tjenester til privat medisinsk virksomhet og det som naturlig hører til dette samt nærliggende tjenester og handel inklusive deltakelse i andre selskaper inkludert handel med tilknyttede produkter, samt alt hva hermed står i forbindelse.
Address
Trondheimsveien 391, 0953 Oslo
Phone
+4791502770
Email
post@sykehusetosloost.no
Website
www.sykehusetosloost.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 357 | 28 027 | 19 743 | 13 581 | 16 193 |
| Staff expenses | −1 657 | −8 397 | −6 875 | −4 348 | −3 335 |
| EBITDA | 612 | 10 321 | 2 289 | −702 | 481 |
| Depreciation & amort. | −109 | −275 | −1 091 | −2 097 | −2 231 |
| EBIT | 503 | 10 046 | 1 198 | −2 799 | −1 751 |
| Net financials | −5 | −0 | −66 | −718 | −791 |
| Profit before tax | 498 | 10 045 | 1 132 | −3 517 | −2 541 |
| Tax | −0 | 2 021 | 336 | −201 | −0 |
| Net profit | 498 | 8 025 | 796 | −3 316 | −2 541 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 803 | 11 014 | 15 039 | 16 828 | 16 543 |
| Equity | −671 | 7 554 | 8 950 | 5 634 | 3 093 |
| Long-term debt | 0 | 55 | 201 | 0 | 0 |
| Short-term debt | 2 474 | 3 405 | 5 888 | 11 194 | 13 451 |
| Total debt | 2 474 | 3 460 | 6 089 | 11 194 | 13 451 |
EBITDA margin
3.0%
This company
15.8%
Market median
-81% vs market
20202024
Equity ratio
18.7%
This company
38.2%
Market median
-51% vs market
20202024
Return on equity
-82.2%
This company
18.4%
Market median
-547% vs market
20202024
Net profit margin
-15.7%
This company
8.1%
Market median
-294% vs market
20202024
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
20202024
Debt / equity
4.35×
This company
0.62×
Market median
-602% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
FA Chief Executive Officer | Chief Executive Officer | 2024 |
RK Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KALBAKKENKLINIKKEN AS (this company)
MONETKLINIKKEN ASBoard members of KALBAKKENKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Forough Afrasiabi | Chief Executive Officer | 0 companies |
| Reza Khusrawi | Chief Executive Officer | 0 companies |
| Alamdar Khusrawi | Chairman | 0 companies |